Patent · US Active

Antibody therapy for treatment of diseases associated with gluten intolerance

US8728471B2 · kind B2 · utility

0Cited by
0References
14Claims
0Family size

Assignee

Inventor

Key dates

Filing dateNov 7, 2011
Grant dateMay 20, 2014
Priority date
Expiry dateNov 20, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/12
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention includes a pharmaceutical compositions and methods for treating diseases associated with gluten intolerance in a patient, comprising: administering to the patient an effective amount of an antibody having specific activity against gluten or gluten-derived peptides. Such diseases include, for example, celiac disease and dermatitis herpetiformis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.